Literature DB >> 12902419

Immuno-PET for tumor targeting.

Fook T Lee1, Andrew M Scott.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12902419

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   10.057


× No keyword cloud information.
  10 in total

Review 1.  PET tracers based on Zirconium-89.

Authors:  Yin Zhang; Hao Hong; Weibo Cai
Journal:  Curr Radiopharm       Date:  2011-04

2.  Which radionuclides will nuclear oncology need tomorrow?

Authors:  Jacques Barbet; Jean-François Chatal; François Gauché; Jacques Martino
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-06       Impact factor: 9.236

3.  ARRONAX, a high-energy and high-intensity cyclotron for nuclear medicine.

Authors:  Ferid Haddad; Ludovic Ferrer; Arnaud Guertin; Thomas Carlier; Nathalie Michel; Jacques Barbet; Jean-François Chatal
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-05-09       Impact factor: 9.236

4.  Multifunctional Desferrichrome Analogues as Versatile 89Zr(IV) Chelators for ImmunoPET Probe Development.

Authors:  Casey J Adams; Justin J Wilson; Eszter Boros
Journal:  Mol Pharm       Date:  2017-07-19       Impact factor: 4.939

5.  Target-or-Clear Zirconium-89 Labeled Silica Nanoparticles for Enhanced Cancer-Directed Uptake in Melanoma: A Comparison of Radiolabeling Strategies.

Authors:  Feng Chen; Kai Ma; Li Zhang; Brian Madajewski; Pat Zanzonico; Sonia Sequeira; Mithat Gonen; Ulrich Wiesner; Michelle S Bradbury
Journal:  Chem Mater       Date:  2017-09-06       Impact factor: 9.811

6.  Ultrasmall Core-Shell Silica Nanoparticles for Precision Drug Delivery in a High-Grade Malignant Brain Tumor Model.

Authors:  Rupa Juthani; Brian Madajewski; Barney Yoo; Ulrich Wiesner; Michelle S Bradbury; Cameron W Brennan; Li Zhang; Pei-Ming Chen; Feng Chen; Melik Z Turker; Kai Ma; Michael Overholtzer; Valerie A Longo; Sean Carlin; Virginia Aragon-Sanabria; Jason Huse; Mithat Gonen; Pat Zanzonico; Charles M Rudin
Journal:  Clin Cancer Res       Date:  2019-09-12       Impact factor: 12.531

7.  Melanocortin-1 Receptor-Targeting Ultrasmall Silica Nanoparticles for Dual-Modality Human Melanoma Imaging.

Authors:  Feng Chen; Xiuli Zhang; Kai Ma; Brian Madajewski; Miriam Benezra; Li Zhang; Evan Phillips; Melik Z Turker; Fabio Gallazzi; Oula Penate-Medina; Michael Overholtzer; Mohan Pauliah; Mithat Gonen; Pat Zanzonico; Ulrich Wiesner; Michelle S Bradbury; Thomas P Quinn
Journal:  ACS Appl Mater Interfaces       Date:  2018-01-24       Impact factor: 9.229

Review 8.  CD44v6-Targeted Imaging of Head and Neck Squamous Cell Carcinoma: Antibody-Based Approaches.

Authors:  Diana Spiegelberg; Johan Nilvebrant
Journal:  Contrast Media Mol Imaging       Date:  2017-06-20       Impact factor: 3.161

9.  Synthesis and Feasibility Evaluation of a new Trastuzumab Conjugate Integrated with Paclitaxel and 89Zr for Theranostic Application Against HER2-Expressing Breast Cancers.

Authors:  Joo Hee Jang; Sang Jin Han; Jung Young Kim; Kwang Il Kim; Kyo Chul Lee; Chi Soo Kang
Journal:  ChemistryOpen       Date:  2019-04-08       Impact factor: 2.911

10.  Preclinical Pharmacokinetics and Dosimetry of an 89Zr Labelled Anti-PDL1 in an Orthotopic Lung Cancer Murine Model.

Authors:  Anis Krache; Charlotte Fontan; Carine Pestourie; Manuel Bardiès; Yann Bouvet; Pierre Payoux; Etienne Chatelut; Melanie White-Koning; Anne-Sophie Salabert
Journal:  Front Med (Lausanne)       Date:  2022-01-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.